Otoimmune
1 known investors
Find your way into Otoimmune
598 people in our graph share verified history with the Otoimmune team — schools, employers, funds. One of them is your warm intro.
Hannah Sealunlockedknows Jason Mellad · together at University of Cambridge (overlapped)
knows the team · via University of Leicester
×7knows the team · via University of Cambridge
×2knows the team · via The University of Law
knows the team · via Tulane University
OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.
Founders & leadership
JM
Jason MelladinFounderCo-founder and CEO of OtoImmune, a precision immunology company. Mellad has spent over two decades working in biotech and life sciences, advancing from research roles to executive positions.
DR
Daniel RookeinFounderDaniel Rooke is co-founder and COO of OtoImmune, which develops precision immunology products including mOI Health, an MHRA-registered medical device for immune health testing. He spent over 17 years in law, life sciences, and healthcare, including roles as senior lawyer, general counsel at a rare disease biotech, and co-founder of Start Codon, an early-stage venture builder and fund.
Investors · 1
Frequently asked questions
- What does Otoimmune do?
- OtoImmune is developing precision immunology products under its mOI and mOI Health brands. The page provides no further detail about the specific products, technology, or target customers.
- Who founded Otoimmune?
- Otoimmune was founded by Jason Mellad, Daniel Rooke.
- Who are Otoimmune's investors?
- Otoimmune's investors include AlbionVC.